Insider Transactions in Q4 2020 at Praxis Precision Medicines, Inc. (PRAX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 10
2020
|
Marcio Souza Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,846
+13.59%
|
$99,996
$26.08 P/Share
|
|
Nov 02
2020
|
Lauren Mastrocola Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,218
+50.0%
|
$36,654
$3.3 P/Share
|
|
Oct 20
2020
|
Bsof Parallel Master Fund L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
7,800,553
+22.66%
|
-
|
|
Oct 20
2020
|
Clarus Lifesciences Iii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
7,800,553
+22.66%
|
-
|
|
Oct 20
2020
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,442,080
+50.0%
|
-
|
|
Oct 20
2020
|
Stefan Vitorovic Director |
BUY
Conversion of derivative security
|
Indirect |
2,689,329
+50.0%
|
-
|
|
Oct 20
2020
|
Marcio Souza Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
20,604
+50.0%
|
-
|